🩸 HematologyInjection 2,000 Units
Retacrit
epoetin alfa-epbx
RETACRIT is an erythropoiesis-stimulating agent (ESA) indicated for: Treatment of anemia due to o Chronic Kidney Disease (CKD) in patients on dialysis and not on dialysis. o Zidovudine in patients with Human Immunodeficiency Virus (HIV) infection.
Form
Injection 2,000 Units
Uses
3
Side effects
1
Category
Hematology
01
What is Retacrit used for?
- RETACRIT is an erythropoiesis-stimulating agent (ESA) indicated for:
- Treatment of anemia due to o Chronic Kidney Disease (CKD) in patients on dialysis and not on dialysi
- Reduction of allogeneic red blood cell (RBC) transfusions in patients undergoing elective, noncardia
02
epoetin alfa-epbx side effects
Common side effects of epoetin alfa-epbx include:
Consult prescribing information for side effects
CommonModerateLess common
03
epoetin alfa-epbx warnings & precautions
- Increased Mortality, Myocardial Infarction, Stroke, and Thromboembolism: Using ESAs to target a hemoglobin level of greater than 11
- Use caution in patients with coexistent cardiovascular disease and stroke.
- Increased Mortality and/or Increased Risk of Tumor Progression or Recurrence in Patients with Cancer.
Loading FDA data…
04
Frequently asked questions
05
Related medications
Share
Share this drug info.
Help friends and family understand Retacrit in plain language.
Disclaimer: This information is sourced from the FDA openFDA database and is provided for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before starting or changing medication.